ANDA 203184, held by Impax Labs Inc. Pyridostigmine Bromide.
As of Nov 16, 2026, ANDA 203184 (Pyridostigmine Bromide), held by Impax Labs Inc, was first approved by FDA on Sep 15, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 15, 2015 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Pyridostigmine Bromide180MG ยท tablet, extended release;oral | Pyridostigmine Bromide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters